Therapy for Migraine Prevention in Children 6-11 Years of Age
Clinical trial NCT04050293 · TERMINATED
Trial details
- NCT number
- NCT04050293
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-14
- Primary completion
- 2023-03-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.